Iperion Ltd
IPR
Company Profile
Business description
Iperion Ltd is engaged in the process of commercializing a novel antimicrobial coating product, being marketed under the name Pathoglaze. The company is engaged in manufacturing, selling, distributing, importing, and exporting a self-cleaning, transparent, antimicrobial surface coating product.
Contact
c/o Duncan Cotterill
50 Customhouse Quay
Level 5 Tower Building
WellingtonNTL6011
NZLT: +64 272428485
Sector
Financial Services
Stock type
Cyclical
Industry
Shell Companies
Fiscal Year End
31 March 2026
Employees
Stocks News & Analysis
stocks
BlackRock earnings: Market gains and inflows drive AUM and revenue to record highs
We plan to raise our fair value estimate of BlackRock stock.
stocks
Our view of ANZ’s strategic plan
Trying to please customers and shareholders with a simpler and leaner bank.
stocks
Perplexing buyback from overvalued ASX share
Earnings continue to grow but investor expectations are too high.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,271.60 | 5.50 | -0.06% |
| CAC 40 | 7,919.62 | 14.64 | -0.18% |
| DAX 40 | 24,236.94 | 150.99 | -0.62% |
| Dow JONES (US) | 46,270.46 | 202.88 | 0.44% |
| FTSE 100 | 9,452.77 | 9.90 | 0.10% |
| HKSE | 25,714.89 | 273.54 | 1.08% |
| NASDAQ | 22,521.70 | 172.91 | -0.76% |
| Nikkei 225 | 47,261.31 | 413.99 | 0.88% |
| NZX 50 Index | 13,311.70 | 34.71 | 0.26% |
| S&P 500 | 6,644.31 | 10.41 | -0.16% |
| S&P/ASX 200 | 8,964.30 | 4.40 | -0.05% |
| SSE Composite Index | 3,864.93 | 0.30 | -0.01% |